Biomolecules & Therapeutics 2024; 32(1): 25-37
Anti-Inflammatory Herbal Extracts and Their Drug Discovery Perspective in Atopic Dermatitis
Jae-Won Lee1,*,†, Eun-Nam Kim2,† and Gil-Saeng Jeong2,*
1Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116,
2College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea
E-mail: (Jeong GS), (Lee JW)
Tel: +82-42-821-5937 (Jeong GS), +82-43-240-6135 (Lee JW)
Fax: +82-42-823-6566 (Jeong GS), +82-43-240-6129 (Lee JW)
The first two authors contributed equally to this work.
Received: May 30, 2023; Revised: July 28, 2023; Accepted: August 1, 2023; Published online: January 1, 2024.
© The Korean Society of Applied Pharmacology. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Atopic dermatitis (AD) is an allergic disorder characterized by skin inflammation. It is well known that the activation of various inflammatory cells and the generation of inflammatory molecules are closely linked to the development of AD. There is accumulating evidence demonstrating the beneficial effects of herbal extracts (HEs) on the regulation of inflammatory response in both in vitro and in vivo studies of AD. This review summarizes the anti-atopic effects of HEs and its associated underlying mechanisms, with a brief introduction of in vitro and in vivo experiment models of AD based on previous and recent studies. Thus, this review confirms the utility of HEs for AD therapy.
Keywords: Herbal extracts, Natural products, Atopic dermatitis, Inflammatory cells, Inflammatory molecules, Keratinocytes

Atopic dermatitis (AD) is a chronic inflammatory skin disorder (CISD) characterized by skin barrier dysfunction and itching (Yang et al., 2020). Its prevalence in developing countries has been increasing (Arafune et al., 2021). The onset of AD is closely related to allergen exposure and is influenced by genetic and environmental factors (Novak and Leung, 2011). Inflammatory cells, such as keratinocytes, Langerhans cells, macrophages, dendritic cells, T lymphocytes, B lymphocytes, and mast cells, play an important role in AD development by generating inflammatory molecules and influencing the activation of immune cells against the invasion of various antigens when the skin barrier is in a damaged state (Kasraie et al., 2013; David Boothe et al., 2017).

Keratinocytes are mainly present in the epidermis and play a pivotal role in host defense by detecting pathogens (Chieosilapatham et al., 2021). This type of cell is the source of inflammatory cytokines, chemokines, and adhesion molecules such as IL-6, IL-8, CCL5 (known as RANTES), CCL17 (known as TARC), CCL22 (known as MDC), and MCP-1 (known as CCL2), which are involved in the amplification of cutaneous inflammation. Langerhans cells, which are antigen-presenting cells (APCs), differentially express toll-like receptors (TLRs) and play a role in pathogen recognition (Mitsui et al., 2004). This type of cell has been known to interact with keratinocytes and T lymphocytes in AD development (Dubrac et al., 2010). Macrophages have TLRs, as seen in Langerhans and dendritic cells, and are abundant in AD skin (Kasraie et al., 2013). An increase in nitric oxide (NO), PGE2, TNF-α, IL-6, and MCP-1 was reported in experimental models of AD (Lim et al., 2014; Choo et al., 2019; Park et al., 2021), and macrophages are known to be a major source of these molecules. Dendritic cells are known as professional APCs, and their presentation of antigens to naïve T cells leads to T cell activation and antigen-specific adaptive immunity (Novak, 2012; Kumar et al., 2019). T helper type 2 (Th2) cells play a crucial role in AD development by generating cytokines, including IL-4, -5, -13, and -31 (Brandt and Sivaprasad, 2011). IL-4/IL-13 promote B cell activation (Nur Husna et al., 2022), and IL-5 has a significant role in the maturation and development of eosinophil (Kouro and Takatsu, 2009). B cells differentiate into plasma cells that produce antibodies against secreted Th2 cytokines, including IgM, IgG, IgA, and IgE (Spiegelberg et al., 1991; Kader et al., 2021). IgE is associated with mast cell and eosinophil activation (Liu et al., 2011). Mast cell-secreted histamine is known to induce itching in AD (Umehara et al., 2021).

Herbal extracts (HEs) have been commonly used in Asia as folk medicines for treating various disorders (Kumar et al., 2013; Yamaguchi et al., 2015; Guo et al., 2017; Zhu et al., 2021). The cumulative evidence indicates that HEs as crude extracts of leaves, stems, bark, and roots contain bioactive compounds that have an ameliorative effect in inflammatory disease, with comparatively fewer side effects than other medicines (Chan et al., 2008; Nagai and Okunishi, 2009; Yang et al., 2017; Lee et al., 2019a; Ryu et al., 2022). Previous and recent investigations based on in vitro and in vivo AD models have shown that HEs and their active compounds exert an ameliorative effect on AD development by suppressing immune cell recruitment and immune cell-derived molecules (Nam et al., 2011; Wu et al., 2011; Choi et al., 2014; Chan et al., 2015; Lim et al., 2016). Interestingly, an insightful review reported that various types of herbal compounds exert effects against AD (Wu et al., 2021). Thus, the advantage of HEs could be emphasized in pharmacological therapy for allergic disorders including AD, suggesting that HEs may be novel therapeutics in AD. In this review, we describe the protective effect of HEs at the level of practically usable extracts against AD based on previous and recent investigations conducted on in vitro and in vivo AD models (Fig. 1).

Figure 1. Anti-AD effects of HEs in AD development. Herbal flower, fruit, branch, stem, leaf, and root extracts ameliorate AD progression by suppressing the generation of inflammatory cell-derived molecules.

To investigate the anti-inflammatory effects of HEs, bioactive fractions, or compounds in in vitro AD studies, a variety of cell lines or primary culture cells have been used with stimulators as follows. Keratinocytes: Human keratinocyte HaCaT cell lines were applied in in vitro studies of AD with TNF-α or TNF-α/IFN-γ as the stimulator (Choi et al., 2010; Lee et al., 2010; Sung et al., 2011a; Sung et al., 2011b; Choi et al., 2012a; Sung et al., 2012; Choi et al., 2014; Lim et al., 2014; Park et al., 2015; Yang et al., 2015a; Choi et al., 2016; Lim et al., 2016; Sung et al., 2016; Kim et al., 2021). Langerhans cells: Langerhans cells derived from mice were stimulated with peptidoglycan (PEG) in an AD study (Matsui et al., 2010). Macrophages: Murine macrophage cell line RAW264.7 was used in in vitro models of AD with its stimulator lipopolysaccharide (LPS) (Ha et al., 2014; Lim et al., 2014; Cho et al., 2018; Kim et al., 2022). Mouse bone marrow-derived macrophages were used for in vitro AD study with LPS stimulation (Lee et al., 2022a). Dendritic cells: Human monocyte-derived dendritic cells were stimulated with a cytokine cocktail (TNF-α/IL-1β/IL-6/PGE2) in an in vitro study of AD (Chan et al., 2015). T lymphocytes: Human Jurkat T cells were activated with anti-CD3/CD28 or PMA plus A23187 (PMACI) in an in vitro study of AD (Lee et al., 2022b). B lymphocytes: Human U266B1 cells were stimulated with LPS (Hwang et al., 2012). Mouse splenic B cells were incubated with stimulator IL-4/LPS in an in vitro study of AD (Higuchi et al., 2013). Mast cells: Human mast cells (HMC-1) and their stimulator PMACI (Oh et al., 2012; Cho et al., 2017), rat peritoneal mast cells (RPMCs) and their stimulator compound 48/80 (Oh et al., 2012), mouse mast cell MC/9 cells and their stimulators compound 48/80 and PMACI (Ha et al., 2014; Sung et al., 2014), and rat basophilic leukemia mast cell line RBL2H3 and its stimulators DNP-specific BSA, PMA/lonomycin, A23187, IgE/HAS, PMACI, and C48/80 (Kim et al., 2013; Lee et al., 2019b; Kim et al., 2021; Lee et al., 2022c) were applied in in vitro studies of AD. Mouse bone-marrow-derived mast cells were incubated with stimulator DNP-specific BSA in an in vitro study of AD (Kim et al., 2013). Splenocytes: Primary splenocytes isolated from mice were used in in vitro studies of AD with its stimulators anti-CD3/CD28 and ovalbumin (OVA) (Shim and Choung, 2014; Cho et al., 2018; Choi et al., 2020).


In an AD-like phenotype mouse model, the increase in dermatitis severity, scratching, and transepidermal water loss (TEWL) is clear, and this increase is associated with an influx of inflammatory cells, including T and B cells, eosinophil, mast cells, and macrophages as well as the generation of those cell-derived molecules. To evaluate the ameliorative effects of HEs, bioactive fraction, or compounds on AD in vivo, different mouse strains have been studied with application of AD inducers as follows. The NC/Nga mouse was first introduced as an AD animal model showing spontaneous AD occurrence (Matsuda et al., 1997). Researchers have been using this mouse in experimental animal models of AD with various AD inducers, such as 2,4-dinitrochlrobenzene (DNCB) (Yang et al., 2011), 2,4-dinitrofluorobenzene (DNFB) (Wu et al., 2011), Dermatophagoides farinae (DfE) (Lee et al., 2010), and house dust mites (HDM) (Lim et al., 2014). The BALB/c mouse has been applied in AD studies with various AD inducers, such as DNCB (Hwang et al., 2012), DfE/DNCB (Choi et al., 2016), oxazolone (Lee et al., 2019b), trimellitic anhydride (TMA) (Choi et al., 2020), and ovalbumin (OVA) challenge/patch (Kim et al., 2021). The C57BL/6 mouse has been used for AD research with inducers DNFB (Nam et al., 2011) and 2,4,6-trinitrochlorobenzene (TNCB) (Kim et al., 2021). The ICR mouse has been treated with AD inducers compound 48/80, histamine (Oh et al., 2012), and oxazolone (Kim et al., 2022). The SKH-1 hairless mouse has been utilized as an AD animal model with its AD inducer DNCB (Lee et al., 2019b).


We briefly introduce the HEs showing ameliorative effects against AD based on previous and recent in vitro and/or in vivo studies from 2010-2022, as summarized in Tables 1-2.

Table 1 Anti-AD effects of HEs in in vitro models of AD (2010–2022)

HaCaT Cells (Keratinocytes)
Plant sourcePOPStimulatorInhibitory effectRef., year
Broussonetia kazinokiTNF-α/IFN-γCCL5, 17, 22Lee et al., 2010
Sophora flavescensRootsTNF-α/IFN-γCCL17, 22, 27Choi et al., 2010
Rehmannia glutinosaTNF-α/IFN-γRANTES, TARC, MDCSung et al., 2011a
Cinnamomum cacciaBarkTNF-α/IFN-γRANTES, TARC, MDCSung et al., 2011b
Illicium verumFruitsTNF-α/IFN-γIL-1β, 6, TARC, MDC, ICAM-1Sung et al., 2012
Platycodi RadixRootsTNF-α/IFN-γTARCChoi et al., 2012a
Platycodon grandiflorumRootsTNF-α/IFN-γTARCChoi et al., 2014
Morus albaTNF-α/IFN-γTARCLim et al., 2014
Sanguisorba officinalisRootsTNF-α/IFN-γIL-8, RANTES, TARC, MDCYang et al., 2015a
Xanthii fructusFruitsTNF-α/IFN-γTARC, MDCPark et al., 2015
Forsythia suspenseFruitsTNF-α/IFN-γRANTES, TARC, MDCSung et al., 2016
Hovenia dulcisBranchesTNF-α/IFN-γIL-6, TNF-α, TARC, MDCLim et al., 2016
Moringa oleiferaLeavesTNF-α/IFN-γIL-1β, 6, TNF-α, CCL17Choi et al., 2016
Patrinia scabiosifoliaTNF-α/IFN-γIL-6, 8, MCP-1, TARCCha et al., 2017
Pyrus ussuriensisTNF-αIL-1β, 6Cho et al., 2018
Perillae herbaLeavesTNF-α/IFN-γIL-6, 8, RANTES, TARCYang et al., 2018
Centella asiaticaTNF-α/IFN-γIL-6, COX-2Lee et al., 2020
Fritillariae thunbergiiTNF-α/IFN-γIL-4, TARC, MDCKim et al., 2021
Rosa davuricaTNF-α/IFN-γNO, PGE2, IL-6,TARCHwang et al., 2021
Indigo pulverataTNF-α/IFN-γMCP-1, RANTES, TARC, MDC, ICAM1Min et al., 2022

POP (parts of the plant), CCL2 (known as MCP-1), CCL5 (known as RANTES), CCL17 (known as TARC), CCL22 (known as MDC), CCL27 (known as CTACK).

Table 1 -1 Anti-AD effects of HEs in in vitro models of AD (2010–2022)

Epidermal Langerhans Cells
Plant sourcePOPStimulatorInhibitory effectRef., year
Schefflera leucanthaPeptidoglycanCCL5, 17Matsui et al., 2010
RAW264.7 Cells (Murine Macrophage)
Plant sourcePOPStimulatorInhibitory effectRef., year
Morus albaLPSNO, PGE2Lim et al., 2014
Artemisia capillarisLPSNOHa et al., 2014
Pyrus ussuriensisLPSNOCho et al., 2018
Cynanchi atratiLPSIL-1β, 6Kim et al., 2022
Bone Marrow-Derived Macrophage
Plant sourcePOPStimulatorInhibitory effectRef., year
Paeonia lactifloraRootsLPSIL-6, 10, 12, TNF-αLee et al., 2022a
THP-1 (Human Monocytes)
Plant sourcePOPStimulatorInhibitory effectRef., year
Duchesnea chrysanthaWholeHDMIL-6, 8, MCP-1Lee et al., 2012
Monocyte-Derived Dendritic Cells
Plant sourcePOPStimulatorInhibitory effectRef., year
Cortex MoutanRootsCytokine cocktailIL-10, 12, 23Chan et al., 2015
Jurkat Cells (Human T lymphocytes)
Plant sourcePOPStimulatorInhibitory effectRef., year
Helianthus annuusLeavesPMACI, Anti-CD3/CD28IL-2Lee et al., 2022b
Mouse Splenic B cells
Plant sourcePOPStimulatorInhibitory effectRef., year
Garcinia mangostanaRindsIL-4/LPSIgE, IFN-γHiguchi et al., 2013

Table 1 -2 Anti-AD effects of HEs in in vitro models of AD (2010–2022)

HMC-1 (Human Mast Cells)
Plant sourcePOPStimulatorInhibitory effectRef., year
Betula platyphyllaRootsPMACIIL-6, 8, TNF-αOh et al., 2012
Diospyros lotusLeavesPMACIIL-6, TNF-αCho et al., 2017
MC/9 (Murine Mast Cells)
Plant sourcePOPStimulatorInhibitory effectRef., year
Gardenia jasminoidesFruitsC48/80HistamineSung et al., 2014
Artemisia capillarisPMACIHistamineHa et al., 2014
RBL2H3 (Rat Mast Cells)
Plant sourcePOPStimulatorInhibitory effectRef., year
Morus bombycisStemsDNP-specific BSAIL-4, TNF-αKim et al., 2013
Quercus acutissimaPMA/lonomycinIL-4Lee et al., 2019b
Fritillariae ThunbergiiA23187IL-4Kim et al., 2021
Grewia tomentosaPMACI, C48/80β-hexosaminidaseLee et al., 2022c
RPMC (Rat Mast Cells)
Plant sourcePOPStimulatorInhibitory effectRef., year
Betula platyphyllaC48/80HistamineOh et al., 2012
Mouse Bone Marrow-Derived Mast Cells
Plant sourcePOPStimulatorInhibitory effectRef., year
Morus bombycisDNP-specific BSAβ-hexosaminidaseKim et al., 2013
Mouse Splenocytes
Plant sourcePOPStimulatorInhibitory effectRef., year
Pyrus ussuriensisLeavesAnti-CD3/CD28IL-4, 13Cho et al., 2018
Rosae multifloraeOvalbuminIL-2, 4, 5, 13, IFN-γChoi et al., 2020

Table 2 Anti-AD effects of HEs in in vivo models of AD (2010–2022)

Nc/Nga mouse
Plant sourcePOPStimulatorInhibitory effectRef., year
Broussonetia kazinokiHDMIL-4, IgELee et al., 2010
Alnus japonicaLeavesHDMIL-4, 5, 13, IgEChoi et al., 2011
Morus albaHDMIgE, HistamineLim et al., 2014
Cordyceps bassianaFruitsDNFBIL-4, IgE, Histamine, IFN-γWu et al., 2011
Rehmannia glutinosaRootsDfEIL-4, TNF-α, IgE, RANTES, TARC, MDCSung et al., 2011a
Cinnamomum cassiaDfEIL-4, TNF-α, IgE, TARC, HistamineSung et al., 2011b
Gardenia jasminoidesDfEIL-4, 6, TNF-α, HistamineSung et al., 2014
Artemisia capillarisDfEIgE, HistamineHa et al., 2014
Forsythia suspenseDfEIL-4, TNF-α, IgE, RANTES, TARC, MDCSung et al., 2016
Chelidonium majusDNCBIL-4, TNF-α, IgEYang et al., 2011
Psidium guajavaLeavesDNCBIL-4, 5, 13, TNF-α, IgE, TARC, IFN-γChoi et al., 2012b
Chrysanthemum borealeFlowersDNCBIgEYang et al., 2012
Platycodi RadixRootsDNCBIL-4, TNF-α, IgE, TARCChoi et al., 2012a
Duchesnea chrysanthaDNCBIgELee et al., 2012
Platycodon grandiflorumDNCBIL-4, 5, 13, TNF-α, IgE, RANTEX, TARCChoi et al., 2014
Solanum tuberosumDNCBIgE, IgG1Shim and Choung, 2014
Hovenia dulcisDNCBIL-1β, IL-4, 5, 12, TNF-α, IgE, CCL5, 11, 17Lim et al., 2016
Patrinia scabiosifoliaDNCBIgECha et al., 2017
Pyrus ussuriensisDNCBIgECho et al., 2018
Pinus densifloraBarkDNCBIL-4, 13, 17A, 31, TNF-α, IgE, IgG1Lee et al., 2018
Spirodela polyrhizaDNCBIL-6, IL-31, IgELee et al., 2021
Indigo Pulverata LevisDNCBTNF-α, IL-6, 13, IgEMin et al., 2022

Table 2 -1 Anti-AD effects of HEs in in vivo models of AD (2010–2022)

BALB/c mouse
Plant sourcePOPStimulatorInhibitory effectRef., year
Betula platyphyllaDNCBIgEOh et al., 2012
Schizonepeta tenuifoliaDNCBIL-6, TNF-α, IgEChoi et al., 2013
Chamaecyparis obtuseDNCBIL-1β, IL-6, IgEYang et al., 2015b
Artemisia argyiDNCBIL-1β, IL-4, 6, IgE, Histamine, IFN-γHan et al., 2016
Angelicae dahuricaeDNCBIL-4, 6, 10, 12, TNF-α, IgEKu et al., 2017
Combretum quadrangulareLeavesDNCBIL-6, 13Park et al., 2020
Centella asiaticaLeavesDNCBIL-4, 5, 6, 10, TNF-αLee et al., 2020
Rosa davuricaLeavesDNCBIL-6, IgEHwang et al., 2021
Indigo Pulverata LevisDNCBIL-6, 13, TNF-α, IgEMin et al., 2022
Paeonia lactifloraDNCBIL-6, 12, 17A, TNF-α, IgELee et al., 2022a
Helianthus annuusDNCBIgELee et al., 2022b
Moringa oleiferaDfE/DNFBIL-4, 5, 10, 17, 22, TNF-α, IgE, IFN-γChoi et al., 2016
Quercus acutissimaOxazoloneIL-1β, IL-4, 33, TNF-αLee et al., 2019b
Rosae multifloraeTMAIL-1β, IL-4, TNF-αChoi et al., 2020
Styphnolobium japonicumSeedsOvalbuminIgEKim and Lee, 2021
C57BL/6 mouse
Plant sourcePOPStimulatorInhibitory effectRef., year
Terminalia chebulaSeedsDNFBIL-31, MMP-9Nam et al., 2011
ICR mouse
Plant sourcePOPStimulatorInhibitory effectRef., year
Cynanchi atratiRootsOxazoloneIL-6, TNF-αKim et al., 2022

Schefflera leucantha (2010)

Matsui et al. (2010) reported that an ethanol leaf extract (ELE) of S. leucantha (SL), which is used as a herbal medicine in China, inhibits CCL5 (known as RANTES) secretion/CCL17 (known as TARC) mRNA expression in PEG-stimulated murine Langerhans cells and histamine generation in IgE-stimulated murine mast cells.

Broussonetia kazinoki (2010)

Previous in vitro and in vivo results have shown that an ethanol heartwood extract (EHE) of B. kazinoki (BK) decreases the mRNA expression of CCL5, CCL17, and CCL22 (known as MDC) in TNF-α/IFN-γ-stimulated human keratinocyte HaCaT cells, and topical application of BKEHE ameliorates AD-like skin lesions, mast cell influx, and IgE/IL-4 secretion in HDM-exposed NC/Nga mice (Lee et al., 2010).

Sophora flavescens (2010)

The in vitro results confirm that PC downregulates the mRNA expression of CCL17, CCL22, and CCL27 (known as CTACK) in TNF-α/IFN-γ-stimulated HaCaT cells (Choi et al., 2010).

Cordyceps bassiana (2011)

It was previously shown that topical application of the butanol fraction (BF) of C. bassiana (CB) fruiting bodies reduces AD symptoms in NC/Nga mice with DNFB-induced AD based on suppression of the dermatitis score, mast cell influx, serum histamine/IgE, and the expression of IL-4/IFN-γ (Wu et al., 2011).

Alnus japonica (2011)

Topical application of an ethanol leaf and bark extract (ELBE) of A. japonica (AJ) attenuates AD severity in HDM-treated NC/Nga mice by inhibiting eosinophil numbers, plasma IgE, serum IL-4, -5, and -13, and mRNA/protein expression of iNOS/COX-2 (Choi et al., 2011).

Rehmannia glutinosa (2011)

The ameliorative effects of ethanol root extract (ERE) of R. glutinosa (RG) on AD were evaluated in both in vitro and in vivo (Sung et al., 2011a). In that study, RGERE effectively reduced secretion of TNF-α/IFN-γ-induced RANTES, TARC, and MDC in HaCaT cells. In addition, it inhibited increased ear thickness, mRNA expression of cytokines (IL-4 and TNF-α)/chemokines (RANTES, TARC, and MDC)/adhesion molecules (ICAM-1 and VCAM-1), and serum histamine/IgE in DfE-exposed NC/Nga mice.

Cinnamomum caccia (2011)

A previous AD study showed that an ethanol bark extract (EBE) of C. cassia (CC) exerts anti-inflammatory effects in TNF-α/IFN-γ-stimulated HaCaT cells by attenuating RANTES, TARC, and MDC secretion (Sung et al., 2011b). It also moderately reduced the dermatitis score, serum IgE/TNF-α/histamine, and mRNA expression of molecules (IL-4, TNF-α, and TARC) in the back skin of NC/Nga mice exposed to DfE.

Chelidonium majus (2011)

Researchers have shown the protective effect of ethanol aerial part extract (EAPE) of C. majus (CM) in an in vivo study of AD (Yang et al., 2011), where its administration (oral or topical) led to downregulation of scratching behavior and serum TNF-α/IL-4/IgE in NC/Nga mice of DNCB-induced AD.

Terminalia chebula (2011)

The experimental results from Nam et al. (2011) confirmed that an aqueous seed extract (ASE) of T. chebula (TC) mitigates AD symptoms in vivo. In that study, the topical application of TCASE inhibited ear swelling, eosinophil recruitment, and MMP-9/IL-31-positive cells in DNFB-exposed C57BL/6 mice.

Illicium verum (2012)

Sung et al. (2012a) have shown the in vitro anti-atopic effect of ethanol fruit extract (EFE) of I. verum (IV) and its underlying mechanisms. In that study, IVEFE suppresses the mRNA and protein expression of cytokines/chemokines/adhesion molecules (IL-1β, IL-6, TARC, MDC, and ICAM-1) and the activation of NF-κB/STAT1/MAPK (ERK and p38)/Akt in TNF-α/IFN-γ-stimulated HaCaT cells.

Betula platyphylla (2012)

The modulating effect of B. platyphylla (BP) ERE on AD symptoms has been previously confirmed in vitro and in vivo (Oh et al., 2012). In the in vitro experiments, pretreatment with BPERE (1 mg/mL) remarkably reduced the secretion of histamine in compound 48/80-stimulated rat peritoneal mast cells (RPMCs); 1 mg/mL BPERE also notably suppressed the generation of TNF-α/IL-6/IL-8, nuclear translocation of NF-κB, and the activation of caspase-1 in PMACI-stimulated human mast cell line HMC-1. In the in vivo experiments, oral administration of BPERE (400 mg/kg) was found to contribute to the suppression of scratching behaviors in ICR mice treated with compound 48/80 or histamine. It also exerted a regulatory effect on increased serum IgE in DNCB-exposed BALB/c mice.

Psidium guajava (2012)

The findings of a study from Choi et al. (2012b) showed that the water extract (WE) of leaves of P. guajava (PG) has an anti-AD effect on NC/Nga mice with DNCB-induced AD, reducing dermatitis severity, serum IgE/TARC, and ear mRNA expression of TNF-α/IFN-γ/Th2 cytokines (IL-4, -5, and -13).

Chrysanthemum boreale (2012)

The ameliorative effect of C. boreale (CB) flowers was examined in an experimental animal model of AD. The experimental results indicated its regulatory effect on itching behaviors and serum IgE in DNCB-treated NC/Nga mice (Yang et al., 2012).

Platycodi Radix (2012)

Choi et al. (2012a) evaluated the anti-inflammatory ability of Changkil (CK), which is an aqueous root extract (ARE) of P. Radix (PR), in an experimental model of AD; 50 and 100 μg/mL CK exerted significant inhibition on mRNA/protein expression of TARC in TNF-α/IFN-γ-stimulated HaCaT cells. In addition, topical application of CK ameliorated the severity of dermatitis and ear thickness. It also inhibited the generation of serum IgE/TARC, reduction of serum IL-10, and upregulation of ear TNF-α/IL-4 in NC/Nga mice treated with DNCB.

Duchesnea chrysantha (2012)

An in vitro study by Lee et al. (2012) showed that ethanol whole plant extract (EWPE) of D. chrysantha (DC) has an anti-inflammatory effect in HDM-stimulated human monocytic cell line THP-1, downregulating the release of IL-6, IL-8, and MCP-1 (known as CCL-2). In addition, its anti-inflammatory ability was confirmed in both DNCB-painted NC/Nga mice, showing its regulatory ability on skin dermatitis/serum IgE, and splenocytes from DNCB-painted mice, showing its inhibitory ability on IL-5, IL-13, MCP-1, and eotaxin.

Garcinia mangostana (2013)

Ethanol rind extract (10 μg/mL) of G. mangostana (GM) significantly downregulates IL-4/LPS-induced IgE in splenic B cells from NC/Tnd mice and the mRNA expression of IFN-γ in pokeweed mitogen (PWM)-stimulated lymphocytes (Higuchi et al., 2013). Its oral administration also reduces the severity of dermatitis, plasma IgE generation, eosinophil/mast cell influx, and mRNA expression of IL-4, IFN-γ, MDC and eotaxin-2 in NC/Tnd mice, a model for human AD.

Morus bombycis (2013)

The anti-AD effect of a methanol stem extract (MSE) of M. bombycis (MB) was reported in an in vitro study (Kim et al., 2013). In that study, MBMSE reduced the release of β-hexosaminidase in antigen (AG)-stimulated mast cells, such as rat basophilic leukemia mast cell line RBL-2H3 and bone marrow mononuclear cells (BMMCs). In particular, 100 μg/mL MBMSE remarkably suppressed the mRNA and protein of TNF-α/IL-4 and the activation of Syk, AKT, and MAPK (ERK, p38, and JNK) in AG-stimulated RBL-2H3 cells.

Schizonepeta tenuifolia (2013)

The in vivo results from Choi et al. (2013) showed that treatment with S. tenuifolia (ST) extract exerts a protective effect on skin dermatitis, serum IgE/TNF-α/IL-6 and dorsal skin NF-κB/MAPK activation in BALB/c mice treated with DNCB.

Gardenia jasminoides (2014)

The experimental results from Sung et al. (2014) confirmed that pretreatment with 400 µg/mL EFE of G. jasminoides (GJ) inhibits 48/80-induced histamine in the MC/9 murine mast cell line. It was also revealed that the GJEFE active compound, 100 μM geniposide, suppressed histamine release in 48/80-stimulated MC/9 cells (Sung et al., 2014). In the in vivo study, the topical application of 400 μg/mL GJEFE significantly reduced epidermal thickening, mast cell influx, serum IL-4/histamine, ear IL-4, IL-6, and TNF-α mRNA in NC/Nga mice of DfE-induced AD.

Platycodon grandiflorum (2014)

Saponin fraction (SF) from ARE of P. grandiflorum (PG) (1 and 2 μg/mL) and its active compound platycodin D (1 and 2 μM) dose-dependently attenuate the mRNA/protein expression of TARC and the activation of NF-κB/STAT1 in TNF-α/IFN-γ-stimulated HaCaT cells (Choi et al., 2014). Moreover, SF and platycodin D induce HO-1 upregulation and Nrf2 activation in HaCaT cells, while 2 mg/kg oral administration of SF alleviates the dermatitis score, ear swelling, mast cell influx, serum IgE/TARC, and the mRNA expression of cytokines and chemokines (IL-4, -5, -13, TNF-α, IFN-γ, and TARC) in DNCB-painted NC/Nga mice.

Solanum tuberosum (2014)

Oral administration of S. tuberosum (ST) ethanol extract resulted in protective effects with respect to ear swelling/scratching behaviors and an inhibitory effect on serum IgE/IgG1 in DNCB-treated NC/Nga mice (Shim and Choung, 2014). The experimental results also showed that splenocytes isolated from NC/Nga mice administered with ST extract suppress IL-4, -12, -13, and IFN-γ stimulation.

Morus alba (2014)

Lim et al. (2014) examined whether a M. alba (MA) ethanol extract could regulate AD development through in vitro and in vivo studies. Their results indicated that 100 μg/mL MA ethanol extract significantly suppresses LPS-induced NO/PGE2 generation in mouse macrophage RAW264.7 cells and TNF-α/IFN-γ-induced TARC production in HaCaT cells. Furthermore, its anti-AD effect was confirmed in NC/Nga mice treated with HDM, showing an ameliorating effect on skin dermatitis and plasma IgE/histamine.

Artemisia capillaris (2014)

A. capillaries (AC) ethanol extract was confirmed to suppress the generation of NO in LPS-stimulated RAW264.7 cells and the secretion of histamine in PMACI-stimulated MC/9 cells (Ha et al., 2014). Topical administration of AC was shown to ameliorate the dermatitis scores and plasma histamine/IgE in DfE-sensitized Nc/Nga mice.

Sanguisorba officinalis (2015)

The anti-inflammatory effects of S. officinalis (SO) ERE were reported in an in vitro study by Yang et al. (2015a). In that study, 50 and 100 μg/mL SOERE significantly decreased the mRNA/protein expression of chemokines (RANTES, TARC, MDC, and IL-8) in TNF-α/IFN-γ-stimulated HaCaT cells. Moreover, its regulatory effect on TNF-α/IFN-γ-induced STAT1 and NF-κB activation was notable in HaCaT cells.

Cortex Moutan (2015)

An in vitro study by Chan et al. (2015) showed the anti-AD effect of gallic acid (GA), the active component of Cortex Moutan (CM), which is known as the dried root cortex (DRC) of Paeonia suffruticosa Andrews. The experimental results revealed that 200 μg/mL GA significantly inhibits the expression of surface makers (CD40, CD80, CD83, CD86, CD11c, and HLA-DR) in cytokine cocktail-stimulated monocyte-derived dendritic cells. CA also inhibits the generation of IL-10, IL-12p40, and IL-23 in activated dendritic cells.

Xanthii fructus (2015)

The ethanol extract of X. fructus (XF), the dried fruit (DF) of Xanthium strumarium L., has regulatory effects on the production of cytokines and the activation of transcription factors in activated epithermal keratinocytes (Park et al., 2015). In brief, treatment with XF ethanol extract (10 μg/mL) significantly inhibited TNF-α/IFN-γ-induced upregulation of TARC and MDC mRNA/protein expression in HaCaT cells. It also suppressed the activation of NF-κB, STAT1, and p38 activation in TNF-α/IFN-γ-stimulated HaCaT cells.

Chamaecyparis obtusa (2015)

The experimental results from Yang et al. (2015b) confirm that the volatile organic compounds (VOC) of C. obtusa (CO) have anti-AD effects in BALB/c mice of DNCB-induced AD by modulating skin dermatitis, serum IgE, and skin mRNA of IL-1β and IL-6.

Forsythia suspensa (2016)

Sung et al. (2016) demonstrated the protective effect of F. suspense (FS) EFE on AD development both in vitro and in vivo. In the in vitro experiments, 200 and 400 μg/mL FSEFE had the ability to inhibit the generation of RANTES, TARC, and MDC in TNF-α/IFN-γ-stimulated HaCaT cells. In addition, forsythiaside, phillyrin, pinoresinol, and phylligenin, which are the active compounds of FSEFE, had an inhibitory effect on TNF-α/IFN-γ-induced RANTES, TARC, and MDC in HaCaT cells. In the in vivo experiments, FSEFE significantly suppressed the dermatitis score, ear thickness, eosinophil/mast cell influx in back skin, serum TNF-α/histamine/IgE, and ear mRNA of molecules (IL-4, TNF-α, RANTES, TARC, MDC, ICAM-1, and VCAM-1) in a NC/Nga mouse model of DfE-induced AD.

Hovenia dulcis (2016)

It was previously examined whether an ethanol branch extract (EBRE) of H. dulcis (HD) and its active compound methyl vanillate (MV) have a modulatory effect on AD development via in vitro and in vivo studies (Lim et al., 2016). The experimental results showed that HDEBRE (5 and 10 μg/mL) and MV (5 and 10 μM) exert a suppressive effect on the mRNA expression of cytokines/chemokines (TNF-α, IL-6, TARC, and MDC) and activation of MAPK (ERK, JNK, and p38) in TNF-α/IFN-γ-stimulated HaCaT cells. Furthermore, oral administration of HDEBRE effectively ameliorated skin dermatitis, mast cell influx, increased serum IgE, and upregulation of skin mRNA of cytokines/chemokines (IL-1β, -4, -5, -12; IFN-γ; CCL5, 11, 17) and GATA3 in a DNCB-painted NC/Nga mouse model.

Moringa oleifera (2016)

M. oleifera (MO) ELE suppresses the mRNA expression of cytokines/chemokines (TNF-α, IL-6, IL-1β, and CCL17) and the activation of MAPK (ERK and JNK) in TNF-α/IFN-γ-stimulated HaCaT cells (Choi et al., 2016). Furthermore, its protective effect on AD was confirmed in BALB/c mice of DfE/DNCB-induced AD, showing inhibitory ability on skin dermatitis, mast cell recruitment, plasma IgE/IgG2a, and ear mRNA of various factors (TNF-α; IL-4, -5, -10, -17, -22, -31, -32; IFN-γ; CD206; RORγt; and TSLP).

Artemisia argyi (2016)

Oral administration of A. argyi (AA) ethanol extract has a regulatory effect on serum histamine/IgE/IL-1β/IL-4/IL-6/IFN-γ, lymph nodes mRNA of IL-1β/IL-4/IL-6/IL-13/IFN-γ/GM-CSF, and activation of Lyn, Syk, MAPK (ERK, JNK, and p38), PI3K, AKT, and IκBα in lymph nodes of DNCB-induced AD like BALB/c mice (Han et al., 2016).

Diospyros lotus (2017)

In a previous report on experimental models of AD, it was reported that the D. lotus (DL) ELE has ameliorative effects (Cho et al., 2017). In that study, the inhibitory effect of DLELE had an on the generation of TNF-α and IL-6 in PMACI-stimulated HMC-1 cells. In a hairless mouse model of DNFB/HDM-induced AD, oral administration of 20 mg/kg DLELE effectively reduced skin dermatitis, mast cell influx in ear, and serum IL-4/IgE.

Angelicae dahuricae (2017)

A. dahuricae (AD) is known as Chinese Angelica and also as Baig-Ji in Korea. WE of AD has an ameliorative effect on DNCB-induced AD in BALB/c mice, suppressing the increases in levels of mast cells/CD4+ cells; immune cells (neutrophils, eosinophils, and monocytes); IgE; IL-4, -6, -10, and -12; and TNF-α (Ku et al., 2017).

Patrinia scabiosifolia (2017)

P. scabiosifolia (PS) has been used as traditional medicine in inflammatory disease in East Asia, including in Korea, and its reductive effect was confirmed not only in TNF-α/IFN-γ-induced IL-6/IL-8/MCP-1/TARC in vitro (HaCaT cells) but also in DNCB-induced IgE in vivo (NC/Nga mice) (Cha et al., 2017).

Pyrus ussuriensis (2018)

It has been examined whether P. ussuriensis (PU) ELE can alleviate AD-like symptoms (Cho et al., 2018). The in vitro experimental results revealed that PUELE has an inhibitory ability on the generation of NO in LPS-stimulated RAW264.7 cells and the secretion of IL-1β/IL-6 in TNF-α-stimulated HaCaT cells. The results also indicated that 8 μg/mL PUELE significantly decreases the anti-CD3/anti-CD28-induced production of IL-4 and IL-13 in splenocytes isolated from C57BL/6 mice. Furthermore, rutin, a major constituent of PUELE, significantly inhibits IL-6 production in TNF-α-stimulated HaCaT cells. In an in vivo model, PUELE suppresses the severity of skin dermatitis, scratching tendency, TEWL, and serum IgE in an experimental NC/Nga mouse model of DNCB-induced AD.

Perillae Herba (2018)

ELE of P. Herba (PH), which is distributed in Asia, has been reported to exert an inhibitory ability in TNF-α/IFN-γ-induced TARC/RANTES/IL-6/IL-8 secretion and MAPK activation in HaCaT cells (Yang et al., 2018).

Pinus densiflora (2018)

It was previously reported that methanol bark extract (MBE) of P. densiflora (PD), which is known as Korean red pine, has an anti-AD effect on DNCB-exposed Nc/Nga mice by mitigating AD-like skin lesions, scratching behavior, serum IgG1, and dorsal skin mRNA of IL-4/IL-13/IL-17A/IL-31/TNF-α (Lee et al., 2018).

Quercus acutissima (2019)

A recent study confirmed the protective effect of Q. acutissima (QA) ethanol shell extract (ESE) using AD-like experimental models (Lee et al., 2019b). The in vitro results indicated that pretreatment with QAESE and its active compounds (gallic acid and ellagic acid) inhibited the mRNA expression of IL-4 in PMA/lonomycin-stimulated RBL-2H3 cells. In addition, QAESE, gallic acid, and ellagic acid decreased the release of β-hexosaminidase in IgE/DNP-BSA-stimulated RBL-2H3 cells. In an experimental BALB/c mouse model of oxazolone-induced AD, QAESE demonstrated a regulatory effect on the mRNA expression of TNFα, IL-1β, IL-4, and IL-33 in mouse ear. Furthermore, QAESE ameliorates not only AD-like skin lesions but also serum IL-4/IgE upregulation in a SKH-1 hairless mouse model of DNCB-induced AD. In these models, QAESE also exerts a suppressive effect on mast cell influx and the mRNA expression of TNFα, IL-1β, IL-4, IL-25, and IL-33 in mouse ear.

Rumex japonicus (2019)

Recently, the anti-AD effect of ERE of R. japonicus (RJ) has been reported in both in vitro and in vivo studies (Yang et al., 2019). In that report, 25 and 50 μg/mL RJERE was shown to inhibit ERK, AKT, and IκBα phosphorylation in TNF-α-stimulated HaCaT cells. In addition, 4 and 8 mg/mL RJERE decreased DNCB-induced upregulation of ear thickness and spleen weight.

Rosae multiflorae (2020)

Choi et al. (2020) recently demonstrated the anti-AD effect of R. multiflorae (RM) extract both in vitro and in vivo. In the in vitro experiments, RM extract (200 and 400 μg/mL) attenuated the secretion of cytokines (IL-2, -4, -5, and -13 and IFN-γ) and the activation of STAT6 in OVA-stimulated splenocytes isolated from BALB/c mouse. In addition, RM extract exerted an inhibitory effect on CD3/CD28-induced IL-2 in CD4+ T cells isolated from splenocytes of BALB/c. In the in vivo experiments, oral administration of 400 mg/kg RM extract significantly reduced ear thickness, ear cytokines (IL-1β, IL-4, and TNF-α), and serum IgE in TMA-induced AD-like BALB/c mice. RM extract also demonstrated an inhibitory ability on the mRNA expression of Th2 cytokines in draining lymph nodes in a TMA-induced AD-like mouse model.

Combretum quadrangulare (2020)

A recent study reported that an ethanol leaf and stem extract (ELSE) of C. quadrangulare (CQ) attenuates serum IgE, blood eosinophil, skin mast cells, and tissue IL-6/IL-13-TARC/TSLP in AD BALB/c mice induced by DNCB (Park et al., 2020). CQELSE also inhibited the activation of MAPK (ERK, JNK, and p38) in skin lysate. In particular, 400 mg/kg CQELSE exerted notable in vivo anti-AD effects.

Centella asiatica (2020)

C. asiatica (CA), known as a medicinal plant, is distributed in Southeast Asia. A recent finding from Lee et al. (2020) showed the anti-AD effect of CA both in vitro and in vivo. In their study, pretreatment with CAELE dose-dependently reduced the expression of COX-2 and IL-6 in TNF-α/IFN-γ-stimulated HaCaT cells. Treatment with CAELE had an ameliorative effect on the increase in ear thickness, lymph node weight, and ear mast cell/TNF-α/IL-4/IL-5/IL-6/IL-10/iNOS/COX-2/CXCL9 in DNCB-exposed BALB/c mice. CAELE also decreased the DNCB-induced upregulation of TNF-α/COX-2/MAC-1/IL-6 expression and p38 activation.

Fritillariae thunbergii (2021)

A recent study confirmed the protective effect of a F. thunbergii (FT) chloroform fraction of ethanol extract (CFEE) on AD based on both in vitro and in vivo studies (Kim et al., 2021). In that study, 50 μg/mL FTCFEE notably downregulated the generation of TARC/MDC/IL-4 and upregulated the mRNA expression of FLG/INV/AQP-3 in TNF-α/IFN-γ-stimulated HaCaT cells, with an inhibitory ability on MAPK activation as well as β-hexosaminidase activity, IL-4 production, and ERK/p38 MAPK activation in A23187-stimulated RBL2H3 cells. The in vivo results showed that the topical application of FTCFEE (100 mg/mL) reduced increased levels of ear thickness, scratching behaviors, and SCORing Atopic Dermatitis (SCORAD) index in a BALB/c mouse model of DNCB-induced AD. In addition, the inhibitory effect of FTCFEE on the influx of mast cells, CD4+ T cells, and CD8+ T cells was confirmed by histopathological analysis.

Styphnolobium japonicum (2021)

The anti-AD effect of sophoricoside isolated from an ethanol seed extract of S. japonicum (SJ) was recently examined in experimental models of AD (Kim and Lee, 2021). In vitro results showed that sophoricoside attenuated IL-5/IL-13 bioactivity in a murine pre-B cell line, BaF- B03 cells. Their results also indicated that sophoricoside could inhibit naïve CD4+ T cells (isolated from spleens and lymph nodes of C57BL/6 mice) and differentiate various Th cell subtypes (Th1, 2, and 17) by downregulating the mRNA expression of transcription factors such as T-bet. Furthermore, in vivo results indicated that topical application of 30 mg/kg sophoricoside notably inhibited serum IgE, mast cell influx, and dermal thickness in a BALB/c mouse model of OVA challenge and patch-induced AD. Sophoricoside also reduced AD symptoms in a C57BL/6 mouse model of TNCB-induced AD by ameliorating skin dermatitis and mast cell recruitment.

Rosa davurica (2021)

R. davurica (RD) has various biological properties (e.g., antioxidant and anti-inflammatory) and is known to be distributed in China, Japan, and Korea. The experimental results of Hwang et al. (2021) confirmed the beneficial effect of RD in an experimental model of AD. In that study, ELE of RD (10, 30, and 100 μg/mL) significantly mitigates TNF/IFN-γ-induced NO/PGE2/TARC/IL-6 generation, iNOS/COX-expression, MAPK activation, and NF-κB activation in HaCaT cells. In DNCB-induced AD BALB/c mice, topical administration of RDELE inhibited the DNCB-induced upregulation of skin/ear thickness, lymph node/spleen size, blood leukocytes, and serum IgE/IL-6/ALT/AST/CREA/BUN (Hwang et al., 2021).

Spirodela polyrhiza (2021)

Ethanol extract of S. polyrhiza (SP) decreases mast cell influx, IgE, IL-6, and IL-31 in DNCB-exposed Nc/Nga mice (Lee et al., 2021). This anti-AD effect is further enhanced by combination with Olea europaea leaf extract in treatment.

Cynanchi atrati (2022)

Recent in vitro results from Kim et al. (2022) confirmed that pretreatment with 10 μg/mL ERE of C. atrati (CA) decreases mRNA expression of IL-6/IL-1β and the activation of NF-κB in LPS-stimulated RAW264.7 cells. In that study, CAERE inhibits the mRNA and protein expression of regulator of calcineurin 1 (RCAN1), a known NF-κB inhibitor, in RAW264.7 cells. Furthermore, it was found that sinapic acid (SA), a phenolic constituent of CAERE, suppresses the mRNA expression of IL-6/IL-1β and the activation of IκB in LPS-stimulated RAW264.7 cells. SA also upregulates the mRNA expression of RCAN1 in RAW264.7 cells. In an in vivo study, the topical administration of 10 μg/mL CAERE on ear tissues exerts an ameliorative effect on skin inflammation in an ICR mouse model of oxazolone-induced AD by decreasing ear thickness and the mRNA expression of IL-6/TNF-α.

Grewia tomentosa (2022)

Recently, Lee et al. (2022c) demonstrated the anti-AD effect of G. tomentosa (GT), which is distributed in Asia, both in vitro and in vivo. In that study, the EAPE of GT significantly reduced IgE/HAS-induced β-hexosaminidase release, PMACI-induced β-hexosaminidase, and C48/80-induced β-hexosaminidase release in RBL-2H3 cells. In addition, GTEAPE (50 and 100 μg/mL) attenuated IgE/HAS-induced molecules (IL-1β, -4, -5, -6, -13; TNF-α; MCP-1; TSLP; and TGF-β1) and activation of Syk/PLCγ1/PKCδ/PI3K/AKT/p65/p38/JNK/ERK. In an experimental mouse model of AD induced by anti-DNP IgE/DNP-HAS, the oral administration of GTEAPE ameliorated dermatitis score, ear thickness, serum IgE, ear IL-1β/IL-4/IL-5/IL-6/TNF-α, and MAPK/NF-κB activation.

Indigo Pulverata Levis (2022)

Min et al. (2022) demonstrated the anti-inflammatory effect of I. Pulverata Levis (IPL), known as Chung-Dae in AD study. In the in vitro experiments, WE of IP was shown to suppress the expression of RANTES/TARC/MDC/MCP-1/MIP-3α/ICAM1 and the nuclear translocation of NF-κB in TNF-α/IFN-γ-stimulated HaCaT cells. In the in vivo experiments, the oral administration of IPWE suppressed DNCB-induced spleen hypertrophy, dermatitis, eosinophil/mast cell recruitment, serum IgE/TNF-α, tissue TNF-α/IL-6/IL-13, and activation of ERK/p38/NF-κB.

Paeonia lactiflora (2022)

The ameliorative effect of water root extract (WRE) of P. lactiflora (PL) in an experimental model of AD was recently reported (Lee et al., 2022a). The experimental results indicate that PLWRE has an anti-inflammatory effect in LPS-stimulated bone marrow-derived macrophages by suppressing inflammatory molecules (TNF-α; IL-6, -10, -12; iNOS; and COX-2) and in DNCB-induced AD BALB/c mice by ameliorating serum cytokines (TNF-α, IL-6, and IL-12)/IgE, skin dermatitis, and tissue IL-6/IL-12/IL-17A.

Helianthus annuus (2022)

It was recently reported that ELE of H. annuus (HA) mitigates IL-2 generation following anti-CD3/CD28 or PMACI stimulation in human Jurkat T cells. In addition, HAELE suppresses anti-CD3/CD28-induced TAK, IκBα, MAPK activation, and nuclear translocation of NF-κB. In the in vivo experiments, oral gavage of HAELE was found to mitigate increases in the levels of ear thickness, serum IgE, and lymph node size in DNCB-treated BALB/c mice (Lee et al., 2022b).


Based on previous and current experimental results, we have summarized and described the beneficial effects of HEs beginning with a brief introduction of experimental models of AD. Thus, this review confirms the beneficial properties of HEs and their usefulness in AD therapy. This review also facilitates comprehensive understanding regarding the establishment of AD experimental models by detailing summarized information on the in vitro and in vivo models used in the study of AD. In AD research using HEs, further mechanistic studies and confirmation of safety will facilitate the development of AD drugs and adjuvants for prevention and treatment.


This research was supported by grants from the KRIBB Research Initiative Program (grant no. KGM5522322) and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare (grant no. HN21C0996) of the Republic of Korea.


The authors declare no conflicts of interest.

  1. Arafune, J., Tsujiguchi, H., Hara, A., Shimizu, Y., Hori, D., Nguyen, T. T. T., Suzuki, F., Hamagishi, T., Yamada, Y., Nakamura, H., Yoshikawa, T., Hayashi, K., Shibata, A., Fukutomi, Y., Ohya, Y., Yamanoto-Hanada, K., Muto, G., Hirota, R., Konoshita, T., Kambayashi, Y. and Nakamura, H. (2021) Increased prevalence of atopic dermatitis in children aged 0-3 years highly exposed to parabens. Int. J. Environ. Res. Public Health 18, 11657.
    Pubmed KoreaMed CrossRef
  2. Brandt, E. B. and Sivaprasad, U. (2011) Th2 cytokines and atopic dermatitis. J. Clin. Cell. Immunol. 2, 110.
    Pubmed KoreaMed CrossRef
  3. Cha, K. J., Im, M. A., Gu, A., Kim, D. H., Lee, D., Lee, J. S., Lee, J. S. and Kim, I. S. (2017) Inhibitory effect of Patrinia scabiosifolia Link on the development of atopic dermatitis-like lesions in human keratinocytes and NC/Nga mice. J. Ethnopharmacol. 206, 135-143.
    Pubmed CrossRef
  4. Chan, B. C., Hon, K. L., Leung, P. C., Sam, S. W., Fung, K. P., Lee, M. Y. and Lau, H. Y. (2008) Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. J. Ethnopharmacol. 120, 85-91.
    Pubmed CrossRef
  5. Chan, B. C., Li, L. F., Hu, S. Q., Wat, E., Wong, E. C., Zhang, V. X., Lau, C. B., Wong, C. K., Hon, K. L., Hui, P. C. and Leung, P. C. (2015) Gallic acid is the major active component of cortex moutan in inhibiting immune maturation of human monocyte-derived dendritic cells. Molecules 20, 16388-16403.
    Pubmed KoreaMed CrossRef
  6. Chieosilapatham, P., Kiatsurayanon, C., Umehara, Y., Trujillo-Paez, J. V., Peng, G., Yue, H., Nguyen, L. T. H. and Niyonsaba, F. (2021) Keratinocytes: innate immune cells in atopic dermatitis. Clin. Exp. Immunol. 204, 296-309.
    Pubmed KoreaMed CrossRef
  7. Cho, B. O., Che, D. N., Yin, H. H., Shin, J. Y. and Jang, S. I. (2017) Diospyros lotus leaf and grapefruit stem extract synergistically ameliorate atopic dermatitis-like skin lesion in mice by suppressing infiltration of mast cells in skin lesions. Biomed. Pharmacother. 89, 819-826.
    Pubmed CrossRef
  8. Cho, K., Parveen, A., Kang, M. C., Subedi, L., Lee, J. H., Park, S. Y., Jin, M. R., Yoon, H., Son, Y. K. and Kim, S. Y. (2018) Pyrus ussuriensis Maxim. leaves extract ameliorates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. Phytomedicine 48, 76-83.
    Pubmed CrossRef
  9. Choi, B. M., Oh, G. S., Lee, J. W., Mok, J. Y., Kim, D. K., Jeong, S. I. and Jang, S. I. (2010) Prenylated chalcone from Sophora flavescens suppresses Th2 chemokine expression induced by cytokines via heme oxygenase-1 in human keratinocytes. Arch. Pharm. Res. 33, 753-760.
    Pubmed CrossRef
  10. Choi, D. W., Jung, S. Y., Lee, S. Y., Shon, D. H. and Shin, H. S. (2020) Rosae multiflorae fructus extract improves trimellitic anhydride-induced atopic dermatitis-like symptoms. J. Med. Food 23, 1287-1295.
    Pubmed CrossRef
  11. Choi, E. J., Debnath, T., Tang, Y., Ryu, Y. B., Moon, S. H. and Kim, E. K. (2016) Topical application of Moringa oleifera leaf extract ameliorates experimentally induced atopic dermatitis by the regulation of Th1/Th2/Th17 balance. Biomed. Pharmacother. 84, 870-877.
    Pubmed CrossRef
  12. Choi, J. H., Han, E. H., Park, B. H., Kim, H. G., Hwang, Y. P., Chung, Y. C., Lee, Y. C. and Jeong, H. G. (2012a) Platycodi Radix suppresses development of atopic dermatitis-like skin lesions. Environ. Toxicol. Pharmacol. 33, 446-452.
    Pubmed CrossRef
  13. Choi, J. H., Jin, S. W., Han, E. H., Park, B. H., Kim, H. G., Khanal, T., Hwang, Y. P., Do, M. T., Lee, H. S., Chung, Y. C., Kim, H. S., Jeong, T. C. and Jeong, H. G. (2014) Platycodon grandiflorum root-derived saponins attenuate atopic dermatitis-like skin lesions via suppression of NF-kappaB and STAT1 and activation of Nrf2/ARE-mediated heme oxygenase-1. Phytomedicine 21, 1053-1061.
    Pubmed CrossRef
  14. Choi, J. H., Park, B. H., Kim, H. G., Hwang, Y. P., Han, E. H., Jin, S. W., Seo, J. K., Chung, Y. C. and Jeong, H. G. (2012b) Inhibitory effect of Psidium guajava water extract in the development of 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice. Food Chem. Toxicol. 50, 2923-2929.
    Pubmed CrossRef
  15. Choi, S. E., Park, K. H., Jeong, M. S., Kim, H. H., Lee, D. I., Joo, S. S., Lee, C. S., Bang, H., Choi, Y. W., Lee, M. K., Seo, S. J. and Lee, M. W. (2011) Effect of Alnus japonica extract on a model of atopic dermatitis in NC/Nga mice. J. Ethnopharmacol. 136, 406-413.
    Pubmed CrossRef
  16. Choi, Y. Y., Kim, M. H., Kim, J. H., Jung, H. S., Sohn, Y., Choi, Y. J., Hwang, M. K., Kim, S. H., Kim, J. and Yang, W. M. (2013) Schizonepeta tenuifolia inhibits the development of atopic dermatitis in mice. Phytother. Res. 27, 1131-1135.
    Pubmed CrossRef
  17. Choo, G. S., Lim, D. P., Kim, S. M., Yoo, E. S., Kim, S. H., Kim, C. H., Woo, J. S., Kim, H. J. and Jung, J. Y. (2019) Anti-inflammatory effects of Dendropanax morbifera in lipopolysaccharide-stimulated RAW264.7 macrophages and in an animal model of atopic dermatitis. Mol. Med. Rep. 19, 2087-2096.
    Pubmed KoreaMed CrossRef
  18. David Boothe, W., Tarbox, J. A. and Tarbox, M. B. (2017) Atopic dermatitis: pathophysiology. Adv. Exp. Med. Biol. 1027, 21-37.
    Pubmed CrossRef
  19. Dubrac, S., Schmuth, M. and Ebner, S. (2010) Atopic dermatitis: the role of Langerhans cells in disease pathogenesis. Immunol. Cell Biol. 88, 400-409.
    Pubmed CrossRef
  20. Guo, B. J., Bian, Z. X., Qiu, H. C., Wang, Y. T. and Wang, Y. (2017) Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Ann. N. Y. Acad. Sci. 1401, 37-48.
    Pubmed CrossRef
  21. Ha, H., Lee, H., Seo, C. S., Lim, H. S., Lee, J. K., Lee, M. Y. and Shin, H. (2014) Artemisia capillaris inhibits atopic dermatitis-like skin lesions in Dermatophagoides farinae-sensitized Nc/Nga mice. BMC Complement. Altern. Med. 14, 100.
    Pubmed KoreaMed CrossRef
  22. Han, H. M., Kim, S. J., Kim, J. S., Kim, B. H., Lee, H. W., Lee, Y. T. and Kang, K. H. (2016) Ameliorative effects of Artemisia argyi Folium extract on 2,4dinitrochlorobenzeneinduced atopic dermatitislike lesions in BALB/c mice. Mol. Med. Rep. 14, 3206-3214.
    Pubmed KoreaMed CrossRef
  23. Higuchi, H., Tanaka, A., Nishikawa, S., Oida, K., Matsuda, A., Jung, K., Amagai, Y. and Matsuda, H. (2013) Suppressive effect of mangosteen rind extract on the spontaneous development of atopic dermatitis in NC/Tnd mice. J. Dermatol. 40, 786-796.
    Pubmed CrossRef
  24. Hwang, D. H., Koh, P. O., Kang, C. and Kim, E. (2021) Rosa davurica Pall. improves DNCB-induced atopic dermatitis in mice and regulated TNF-Alpa/IFN-gamma-induced skin inflammatory responses in HaCaT cells. Phytomedicine 91, 153708.
    Pubmed CrossRef
  25. Hwang, J. S., Kwon, H. K., Kim, J. E., Rho, J. and Im, S. H. (2012) Immunomodulatory effect of water soluble extract separated from mycelium of Phellinus linteus on experimental atopic dermatitis. BMC Complement. Altern. Med. 12, 159.
    Pubmed KoreaMed CrossRef
  26. Kader, H. A., Azeem, M., Jwayed, S. A., Al-Shehhi, A., Tabassum, A., Ayoub, M. A., Hetta, H. F., Waheed, Y., Iratni, R., Al-Dhaheri, A. and Muhammad, K. (2021) Current insights into immunology and novel therapeutics of atopic dermatitis. Cell 10, 1392.
    Pubmed KoreaMed CrossRef
  27. Kasraie, S., Tarbox, J. A. and Tarbox, M. B. (2013) Role of macrophages in the pathogenesis of atopic dermatitis. Mediators Inflamm. 2013, 942375.
    Pubmed KoreaMed CrossRef
  28. Kim, B. H. and Lee, S. (2021) Sophoricoside from Styphnolobium japonicum improves experimental atopic dermatitis in mice. Phytomedicine 82, 153463.
    Pubmed CrossRef
  29. Kim, E. Y., Hong, S., Kim, J. H., Kim, M., Lee, Y., Sohn, Y. and Jung, H. S. (2021) Effects of chloroform fraction of Fritillariae Thunbergii Bulbus on atopic symptoms in a DNCB-induced atopic dermatitis-like skin lesion model and in vitro models. J. Ethnopharmacol. 281, 114453.
    Pubmed CrossRef
  30. Kim, J. D., Kim, D. K., Kim, H. S., Kim, A. R., Kim, B., Her, E., Park, K. H., Kim, H. S., Kim, Y. M. and Choi, W. S. (2013) Morus bombycis extract suppresses mast cell activation and IgE-mediated allergic reaction in mice. J. Ethnopharmacol. 146, 287-293.
    Pubmed CrossRef
  31. Kim, S. S., Kim, N. K. and Seo, S. R. (2022) Cynanchi atrati and its phenolic constituent sinapic acid target regulator of calcineurin 1 (RCAN1) to control skin inflammation. Antioxidants (Basel) 11, 205.
    Pubmed KoreaMed CrossRef
  32. Kouro, T. and Takatsu, K. (2009) IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int. Immunol. 21, 1303-1309.
    Pubmed CrossRef
  33. Ku, J. M., Hong, S. H., Kim, H. I., Seo, H. S., Shin, Y. C. and Ko, S. G. (2017) Effects of Angelicae dahuricae Radix on 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model. BMC Complement. Altern. Med. 17, 98.
    Pubmed KoreaMed CrossRef
  34. Kumar, H., Song, S. Y., More, S. V., Kang, S. M., Kim, B. W., Kim, I. S. and Choi, D. K. (2013) Traditional Korean East Asian medicines and herbal formulations for cognitive impairment. Molecules 18, 14670-14693.
    Pubmed KoreaMed CrossRef
  35. Kumar, S., Jeong, Y., Ashraf, M. U. and Bae, Y. S. (2019) Dendritic cell-mediated Th2 immunity and immune disorders. Int. J. Mol. Sci. 20, 2159.
    Pubmed KoreaMed CrossRef
  36. Lee, H. P., Choi, W., Kwon, K. W., You, L., Rahmawati, L., Luong, V. D., Kim, W., Lee, B. H., Lee, S., Kim, J. H. and Cho, J. Y. (2022a) Inhibitory effects of Grewia tomentosa Juss. on IgE-mediated allergic reaction and DNCB-induced atopic dermatitis. Plants (Basel) 11, 2540.
    Pubmed KoreaMed CrossRef
  37. Lee, H. S., Kim, E. N. and Jeong, G. S. (2022b) Oral administration of Helianthus annuus leaf extract ameliorates atopic dermatitis by modulation of T cell activity in vivo. Phytomedicine 106, 154443.
    Pubmed CrossRef
  38. Lee, J. K., Ha, H., Lee, H. Y., Park, S. J., Jeong, S. L., Choi, Y. J. and Shin, H. K. (2010) Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice. Biosci. Biotechnol. Biochem. 74, 1802-1806.
    Pubmed CrossRef
  39. Lee, J. S., Kim, I. S., Ryu, J. S., Kim, J. H., Kim, J. S., Kim, D. H. and Yun, C. Y. (2012) The inhibitory effect of Duchesnea chrysantha extract on the development of atopic dermatitis-like lesions by regulating IgE and cytokine production in Nc/Nga mice. Phytother. Res. 26, 284-290.
    Pubmed CrossRef
  40. Lee, J. W., Min, J. H., Kim, M. G., Kim, S. M., Kwon, O. K., Oh, T. K., Lee, J. K., Kim, T. Y., Lee, S. W., Choi, S., Li, W. Y., Ryu, H. W., Ahn, K. S. and Oh, S. R. (2019a) Pistacia weinmannifolia root exerts a protective role in ovalbumin-induced lung inflammation in a mouse allergic asthma model. Int. J. Mol. Med. 44, 2171-2180.
  41. Lee, J. W., Wu, Q., Jang, Y. P. and Choung, S. Y. (2018) Pinus densiflora bark extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by regulating Th1/Th2 balance and skin barrier function. Phytother. Res. 32, 1135-1143.
    Pubmed CrossRef
  42. Lee, S., Jegal, H., Bong, S. K., Yoon, K. N., Park, N. J., Shin, M. S., Yang, M. H., Kim, Y. K. and Kim, S. N. (2019b) Anti-atopic effect of acorn shell extract on atopic dermatitis-like lesions in mice and its active phytochemicals. Biomolecules 10, 57.
    Pubmed KoreaMed CrossRef
  43. Lee, S. Y., Hong, S. H., Kim, H. I., Ku, J. M., Choi, Y. J., Kim, M. J. and Ko, S. G. (2022c) Paeonia lactiflora Pallas extract alleviates antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice. Biomed. Pharmacother. 154, 113574.
    Pubmed CrossRef
  44. Lee, Y., Choi, H. K., N'Deh, K, P. U., Choi, Y. J., Fan, M., Kim, E. K., Chung, K. H. and An, A. J. H. (2020) Inhibitory effect of centella asiatica extract on DNCB-induced atopic dermatitis in HaCaT cells and BALB/c mice. Nutrients 12, 411.
    Pubmed KoreaMed CrossRef
  45. Lee, Y. S., Ryu, H. W., Yang, W. K., Park, M. H., Park, Y. C., Kim, D. Y., Kwon, H. J., Kim, S. Y., Oh, S. R. and Kim, S. H. (2021) A combination of Olea europaea leaf extract and Spirodela polyrhiza extract alleviates atopic dermatitis by modulating immune balance and skin barrier function in a 1-chloro-2,4-dinitrobenzene-induced murine model. Phytomedicine 82, 153407.
    Pubmed CrossRef
  46. Lim, H. S., Ha, H., Lee, H., Lee, J. K., Lee, M. Y. and Shin, H. K. (2014) Morus alba L. suppresses the development of atopic dermatitis induced by the house dust mite in NC/Nga mice. BMC Complement Altern. Med. 14, 139.
    Pubmed KoreaMed CrossRef
  47. Lim, S. J., Kim, M., Randy, A., Nam, E. J. and Nho, C. W. (2016) Effects of Hovenia dulcis Thunb. extract and methyl vanillate on atopic dermatitis-like skin lesions and TNF-alpha/IFN-gamma-induced chemokines production in HaCaT cells. J. Pharm. Pharmacol. 68, 14651479.
    Pubmed CrossRef
  48. Liu, F. T., Goodarzi, H. and Chen, H. Y. (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41, 298-310.
    Pubmed CrossRef
  49. Matsuda, H., Watanabe, N., Geba, G. P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P. W. and Ra, C. (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9, 461-466.
    Pubmed CrossRef
  50. Matsui, K., Wirotesangthong, M., Thanakijcharoenpath, W., Mungmee, C. and Nishikawa, A. (2010) Inhibitory effects of Schefflera leucantha extract on production of allergic mediators by Langerhans cells and mast cells. J. Investig. Allergol. Clin. Immunol. 20, 463-468.
  51. Min, G. Y., Kim, J. H., Kim, T. I., Cho, W. K., Yang, J. H. and Ma, J. Y. (2022) Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro. Int. J. Mol. Sci. 23, 553.
    Pubmed KoreaMed CrossRef
  52. Mitsui, H., Watanabe, T., Saeki, H., Mori, K., Fujita, H., Tada, Y., Asahina, A., Nakamura, K. and Tamaki, K. (2004) Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J. Invest. Dermatol. 122, 95-102.
    Pubmed CrossRef
  53. Nagai, M. and Okunishi, I. (2009) The effect of wasabi rhizome extract on atopic dermatitis-like symptoms in HR-1 hairless mice. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 195-200.
    Pubmed CrossRef
  54. Nam, D. Y., Lee, J. M., Heo, J. C. and Lee, S. H. (2011) Mitigation of 2,4-dinitrofluorobenzene-induced atopic dermatitis-related symptoms by Terminalia chebula Retzius. Int. J. Mol. Med. 28, 1013-1018.
    Pubmed CrossRef
  55. Novak, N. (2012) An update on the role of human dendritic cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 129, 879-886.
    Pubmed CrossRef
  56. Novak, N. and Leung, D. Y. (2011) Advances in atopic dermatitis. Curr. Opin. Immunol. 23, 778-783.
    Pubmed KoreaMed CrossRef
  57. Nur Husna, S. M., Md Shukri, N., Mohd Ashari, N. S. and Wong, K. K. (2022) IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma. PeerJ 10, e13444.
    Pubmed KoreaMed CrossRef
  58. Oh, S. R., Um, J. Y., Choi, H. J., Im, C. K., Kim, K. J., Jung, J. W., Jeong, G. S., Hong, S. H. and Kim, S. J. (2012) Betula platyphylla attenuated mast cell-mediated allergic inflammation in vivo and in vitro. Life Sci. 91, 20-28.
    Pubmed CrossRef
  59. Park, J. H., Hwang, M. H., Cho, Y. R., Hong, S. S., Kang, J. S., Kim, W. H., Yang, S. H., Seo, D. W., Oh, J. S. and Ahn, E. K. (2020) Combretum quadrangulare extract attenuates atopic dermatitis-like skin lesions through modulation of MAPK signaling in BALB/c mice. Molecules 25, 2003.
    Pubmed KoreaMed CrossRef
  60. Park, J. H., Kim, M. S., Jeong, G. S. and Yoon, J. (2015) Xanthii fructus extract inhibits TNF-alpha/IFN-gamma-induced Th2-chemokines production via blockade of NF-kappaB, STAT1 and p38-MAPK activation in human epidermal keratinocytes. J. Ethnopharmacol. 171, 85-93.
    Pubmed CrossRef
  61. Park, J. W., Oh, J. H., Hwang, D., Kim, S. M., Min, J. H., Seo, J. Y., Chun, W., Lee, H. J., Oh, S. R., Lee, J. W. and Ahh, K. S. (2021) 3,4,5-Trihydroxycinnamic acid exerts anti-inflammatory effects on TNF-alpha/IFN-gamma-stimulated HaCaT cells. Mol. Med. Rep. 24, 509.
    Pubmed KoreaMed CrossRef
  62. Ryu, H. W., Lee, J. W., Kim, M. O., Lee, R. W., Kang, M. J., Kim, S. M., Min, J. H., Oh, E. S., Song, Y. N., Jung, S., Ro, H., Kim, D. Y., Park, Y. J., Lee, S. U., Hong, S. T. and Oh, S. R. (2022) Daphnodorin C isolated from the stems of Daphne kiusiana Miquel attenuates airway inflammation in a mouse model of chronic obstructive pulmonary disease. Phytomedicine 96, 153848.
    Pubmed CrossRef
  63. Shim, E. H. and Choung, S. Y. (2014) Inhibitory effects of Solanum tuberosum L. var. vitelotte extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. J. Pharm. Pharmacol. 66, 1303-1316.
    Pubmed CrossRef
  64. Spiegelberg, H. L., O'Connor, R. D., Falkoff, R. J. and Beck, L. (1991) Interleukin-4 induced IgE and IgG4 secretion by B cells from atopic dermatitis patients. Int. Arch. Allergy Appl. Immunol. 94, 181-183.
    Pubmed CrossRef
  65. Sung, Y. Y., Kim, Y. S. and Kim, H. K. (2012) Illicium verum extract inhibits TNF-alpha- and IFN-gamma-induced expression of chemokines and cytokines in human keratinocytes. J. Ethnopharmacol. 144, 182-189.
    Pubmed CrossRef
  66. Sung, Y. Y., Lee, A. Y. and Kim, H. K. (2014) The Gardenia jasminoides extract and its constituent, geniposide, elicit anti-allergic effects on atopic dermatitis by inhibiting histamine in vitro and in vivo. J. Ethnopharmacol. 156, 33-40.
    Pubmed CrossRef
  67. Sung, Y. Y., Yoon, T., Jang, J. Y., Park, S. J. and Kim, H. K. (2011a) Topical application of Rehmannia glutinosa extract inhibits mite allergen-induced atopic dermatitis in NC/Nga mice. J. Ethnopharmacol. 134, 37-44.
    Pubmed CrossRef
  68. Sung, Y. Y., Yoon, T., Jang, J. Y., Park, S. J., Jeong, G. H. and Kim, H. K. (2011b) Inhibitory effects of Cinnamomum cassia extract on atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. J. Ethnopharmacol. 133, 621-628.
    Pubmed CrossRef
  69. Sung, Y. Y., Yoon, T., Jang, S. and Kim, H. K. (2016) Forsythia suspensa suppresses house dust mite extract-induced atopic dermatitis in NC/Nga mice. PLoS One 11, e0167687.
    Pubmed KoreaMed CrossRef
  70. Umehara, Y., Kiatsurayanon, C., Trujillo-Paez, J. V., Chieosilapatham, P., Peng, G., Yue, H., Nguyen, H. L. T., Song, P., Okumura, K., Ogawa, H. and Niyonsaba, F. (2021) Intractable itch in atopic dermatitis: causes and treatments. Biomedicines 9, 229.
    Pubmed KoreaMed CrossRef
  71. Wu, G., Li, L., Sung, G. H., Kim, T. W., Byeon, S. E., Cho, J. Y., Park, C. W. and Park, H. J. (2011) Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice. J. Ethnopharmacol. 134, 504-509.
    Pubmed CrossRef
  72. Wu, S., Pang, Y., He, Y., Zhang, X., Peng, L., Guo, J. and Zeng, J. (2021) A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed. Pharmacother. 140, 11741.
    Pubmed CrossRef
  73. Yamaguchi, K. (2015) Traditional Japanese herbal medicines for treatment of odontopathy. Front. Pharmacol. 6, 176.
    Pubmed KoreaMed CrossRef
  74. Yang, G., Lee, K., An, D. G., Lee, M. H., Ham, I. H. and Choi, H. Y. (2012) Effect of Chrysanthemi borealis flos on atopic dermatitis induced by 1-chloro 2,4-dinitrobenzene in NC/Nga mouse. Immunopharmacol. Immunotoxicol. 34, 413-418.
    Pubmed CrossRef
  75. Yang, G., Lee, K., Lee, M. H., Kim, S. H., Ham, I. H. and Choi, H. Y. (2011) Inhibitory effects of Chelidonium majus extract on atopic dermatitis-like skin lesions in NC/Nga mice. J. Ethnopharmacol. 138, 398-403.
    Pubmed CrossRef
  76. Yang, G., Seok, J. K., Kang, H. C., Cho, Y. Y., Lee, H. S. and Lee, J. Y. (2020) Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int. J. Mol. Sci. 21, 2867.
    Pubmed KoreaMed CrossRef
  77. Yang, H., Ahn, C., Choi, I. G., Choi, W. S., Park, M. J., Lee, S. S., Choi, D. H. and Jeung, E. B. (2015a) Estimation of the environmental effect of natural volatile organic compounds from Chamaecyparis obtusa and their effect on atopic dermatitis-like skin lesions in mice. Mol. Med. Rep. 12, 345-350.
    Pubmed CrossRef
  78. Yang, H. R., Lee, H., Kim, J. H., Hong, I. H., Hwang, D. H., Rho, I. R., Kim, G. S., Kim, E. and Kang, C. (2019) Therapeutic effect of Rumex japonicus Houtt. on DNCB-induced atopic dermatitis-like skin lesions in Balb/c mice and human keratinocyte HaCaT cells. Nutrients 11, 573.
    Pubmed KoreaMed CrossRef
  79. Yang, J. H., Hwang, Y. H., Gu, M. J., Cho, W. K. and Ma, J. Y. (2015b) Ethanol extracts of Sanguisorba officinalis L. suppress TNF-alpha/IFN-gamma-induced pro-inflammatory chemokine production in HaCaT cells. Phytomedicine 14, 1262-1268.
    Pubmed CrossRef
  80. Yang, J. H., Yoo, J. M., Lee, E., Lee, B., Cho, W. K., Park, K. I. and Yeul Ma, J. (2018) Anti-inflammatory effects of Perillae Herba ethanolic extract against TNF-alpha/IFN-gamma-stimulated human keratinocyte HaCaT cells. J. Ethnopharmacol. 211, 217-223.
    Pubmed CrossRef
  81. Yang, Z., Liu, M., Wang, W., Wang, Y., Cao, B., Gao, Y., Chen, H. and Li, T. (2017) Pseudolaric acid B attenuates atopic dermatitis-like skin lesions by inhibiting interleukin-17-induced inflammation. Sci. Rep. 7, 7918.
    Pubmed KoreaMed CrossRef
  82. Zhu, T., Wang, L., Feng, Y., Sun, G. and Sun, X. (2021) Classical active ingredients and extracts of chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke. Oxid. Med. Cell. Longev. 2021, 8868941.
    Pubmed KoreaMed CrossRef

This Article

Cited By Articles
  • CrossRef (0)

Funding Information

Social Network Service